LIVE NOW: FDA Vaccines Advisory Committee Meets on Moderna’s mRNA Influenza Vaccine MFLUSIVA

By The Epoch Times | Created at 2026-06-18 12:32:13 | Updated at 2026-06-20 09:59:57 1 day ago

The FDA Vaccines and Related Biological Products Advisory Committee holds a meeting at 8:30 a.m. ET on June 18 to discuss and make recommendations on the safety and effectiveness of MFLUSIVA (Influenza Vaccine, mRNA), manufactured by Moderna TX Inc., with a requested indication in Biologics License Application STN 125869/0 for t...

Read Entire Article